申请人:Merrell Toraude et Compagnie
公开号:US04435425A1
公开(公告)日:1984-03-06
Fluorinated diaminobutane compounds in vivo are inhibitors of gamma-aminobutyric acid transaminase and have the following formula: ##STR1## wherein: R.sub.1 represents hydrogen, C.sub.1 -C.sub.6 alkyl, or phenyl-(C.sub.1 -C.sub.4 alkyl); R.sub.2 represents hydrogen, C.sub.1 -C.sub.6 alkyl, phenyl-(C.sub.1 -C.sub.4 alkyl), or R.sub.4, where R.sub.4 is as defined below; R.sub.3 represents hydrogen, or, except when R.sub.2 represents R.sub.4, R.sub.4, where R.sub.4 is as defined below; each R.sub.4, independently, represents C.sub.2 -C.sub.5 alkylcarbonyl, phenylcarbonyl, phenyl-(C.sub.1 -C.sub.4 alkyl) carbonyl, or an aminocarboxylic acid residue derived by removal of an hydroxy group from the carboxy moiety of an L-aminocarboxylic acid; and p represents 1 or 2, and pharmaceutically acceptable acid addition salts thereof.
体内的氟代二氨基丁烷化合物是γ-氨基丁酸转氨酶的抑制剂,具有以下结构式:##STR1## 其中:R.sub.1代表氢、C.sub.1-C.sub.6烷基或苯基-(C.sub.1-C.sub.4烷基);R.sub.2代表氢、C.sub.1-C.sub.6烷基、苯基-(C.sub.1-C.sub.4烷基)或R.sub.4,其中R.sub.4如下所定义;R.sub.3代表氢,或除非R.sub.2代表R.sub.4,否则为R.sub.4,其中R.sub.4如下所定义;每个独立的R.sub.4代表C.sub.2-C.sub.5烷基羰基、苯基羰基、苯基-(C.sub.1-C.sub.4烷基)羰基或通过从L-氨基羧酸的羧基中去除羟基而得到的氨基羧酸残基;p代表1或2,以及其药学上可接受的酸盐。